Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Vega-Sanchez (Ciudad de Mexico, Mexico), E. Ramos-Martínez (Ciudad de Mexico, Mexico), I. Buendía-Roldan (Ciudad de Mexico, Mexico), G. Pérez-Rubio (Ciudad de Mexico, Mexico), R. Falfán-Valencia (Ciudad de Mexico, Mexico), M. Mejía (Ciudad de Mexico, Mexico), J. Rojas-Serrano (Ciudad de Mexico, Mexico). Role of the inflammasome in the pathophysiology of antisynthetase-associated interstitial lung disease.. 2377

Member's Comments

No comment yet.

Related content which might interest you: Role of IL23 in the development of fibrotic interstitial lung disease Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Role of the inflammasome in idiopathic pulmonary fibrosis Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Cellular interactions in the pathogenesis of interstitial lung diseases Source: Eur Respir Rev 2015; 24: 102-114 Year: 2015 Role of neutrophil mechanisms of inflammation in pathogenesis of different types of pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 459s Year: 2003 Silica-induced inflammasome activation in vitro and in rat lungs Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy Source: Eur Respir Rev, 31 (163) 210241; 10.1183/16000617.0241-2021 Year: 2022 The role of macrophages in interstitial lung diseases Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017 Year: 2017 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Involvement of RIPK3-regulated necroptosis in IPF pathogenesis. Source: International Congress 2017 – Novel mechanisms and therapeutic targets in lung injury and repair Year: 2017 The NLRP3 inflammasome in chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Investigation of the citrullination pathway in the pathogenesis of fibrotic lung disorders Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006 NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung Source: Eur Respir J 2016; 47: 910-918 Year: 2016 Role of necroptosis in the pathogenesis of COPD Source: International Congress 2019 – Mechanisms underlying acute exacerbation of respiratory disease Year: 2019 PP108 – Role of TRIM-16-mediated lysophagy in COPD pathogenesis Source: ERS Lung Science Conference 2021 Year: 2021 The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Tranilast inhibits pulmonary fibrosis by suppressing TGFbeta-mediated extracellular matrix protein production Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 The role of CX3CL1 and ADAM17 in pathogenesis of diffuse parenchymal lung diseases Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021